Correlation Engine 2.0
Clear Search sequence regions


The Food and Drug Administration (FDA) is announcing the availability of a final recommendation for the revision of the permitted daily exposure (PDE) for the solvent cumene according to the maintenance procedures for the guidance for industry entitled ``Q3C Impurities: Residual Solvents.'' The recommendation was prepared under the auspices of the International Conference on Harmonisation of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH).

Citation

Food and Drug Administration, HHS. International Conference on Harmonisation; final recommendation for the revision of the permitted daily exposure for the solvent cumene according to the maintenance procedures for the guidance Q3C Impurities: Residual Solvents; availability. Notice. Federal register. 2012 Feb 23;77(36):10754-5

Expand section icon Mesh Tags

Expand section icon Substances


PMID: 22379689

View Full Text